The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase

Phillip J. White, Robert W. McGarrah, Paul A. Grimsrud, Shih Chia Tso, Wen Hsuan Yang, Jonathan M. Haldeman, Thomas Grenier-Larouche, Jie An, Amanda L. Lapworth, Inna Astapova, Sarah A. Hannou, Tabitha George, Michelle Arlotto, Lyra B. Olson, Michelle Lai, Guo Fang Zhang, Olga Ilkayeva, Mark A. Herman, R. Max Wynn, David T. ChuangChristopher B. Newgard

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Branched-chain amino acids (BCAA) are strongly associated with dysregulated glucose and lipid metabolism, but the underlying mechanisms are poorly understood. We report that inhibition of the kinase (BDK) or overexpression of the phosphatase (PPM1K) that regulates branched-chain ketoacid dehydrogenase (BCKDH), the committed step of BCAA catabolism, lowers circulating BCAA, reduces hepatic steatosis, and improves glucose tolerance in the absence of weight loss in Zucker fatty rats. Phosphoproteomics analysis identified ATP-citrate lyase (ACL) as an alternate substrate of BDK and PPM1K. Hepatic overexpression of BDK increased ACL phosphorylation and activated de novo lipogenesis. BDK and PPM1K transcript levels were increased and repressed, respectively, in response to fructose feeding or expression of the ChREBP-β transcription factor. These studies identify BDK and PPM1K as a ChREBP-regulated node that integrates BCAA and lipid metabolism. Moreover, manipulation of the BDK:PPM1K ratio relieves key metabolic disease phenotypes in a genetic model of severe obesity. Branched-chain amino acids (BCAA) are strongly associated with metabolic diseases. White et al. demonstrate that the kinase (BDK) and phosphatase (PPM1K) that regulate a rate-limiting BCAA metabolic enzyme, BCKDH, also regulate ATP-citrate lyase, a key lipogenic enzyme, thus identifying a new regulatory node that integrates BCAA and lipid metabolism.

Original languageEnglish (US)
JournalCell Metabolism
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)
ATP Citrate (pro-S)-Lyase
Branched Chain Amino Acids
Lipid Metabolism
Phosphoric Monoester Hydrolases
Phosphotransferases
Metabolic Diseases
Zucker Rats
Glucose
Lipogenesis
Morbid Obesity
Liver
Genetic Models
Enzymes
Fructose
Weight Loss
Transcription Factors
Phosphorylation
Phenotype

Keywords

  • ATP-citrate lyase
  • branched-chain amino acids
  • diabetes
  • lipid metabolism
  • obesity
  • systems physiology

ASJC Scopus subject areas

  • Physiology
  • Molecular Biology
  • Cell Biology

Cite this

White, P. J., McGarrah, R. W., Grimsrud, P. A., Tso, S. C., Yang, W. H., Haldeman, J. M., ... Newgard, C. B. (Accepted/In press). The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase. Cell Metabolism. https://doi.org/10.1016/j.cmet.2018.04.015

The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase. / White, Phillip J.; McGarrah, Robert W.; Grimsrud, Paul A.; Tso, Shih Chia; Yang, Wen Hsuan; Haldeman, Jonathan M.; Grenier-Larouche, Thomas; An, Jie; Lapworth, Amanda L.; Astapova, Inna; Hannou, Sarah A.; George, Tabitha; Arlotto, Michelle; Olson, Lyra B.; Lai, Michelle; Zhang, Guo Fang; Ilkayeva, Olga; Herman, Mark A.; Wynn, R. Max; Chuang, David T.; Newgard, Christopher B.

In: Cell Metabolism, 01.01.2018.

Research output: Contribution to journalArticle

White, PJ, McGarrah, RW, Grimsrud, PA, Tso, SC, Yang, WH, Haldeman, JM, Grenier-Larouche, T, An, J, Lapworth, AL, Astapova, I, Hannou, SA, George, T, Arlotto, M, Olson, LB, Lai, M, Zhang, GF, Ilkayeva, O, Herman, MA, Wynn, RM, Chuang, DT & Newgard, CB 2018, 'The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase', Cell Metabolism. https://doi.org/10.1016/j.cmet.2018.04.015
White, Phillip J. ; McGarrah, Robert W. ; Grimsrud, Paul A. ; Tso, Shih Chia ; Yang, Wen Hsuan ; Haldeman, Jonathan M. ; Grenier-Larouche, Thomas ; An, Jie ; Lapworth, Amanda L. ; Astapova, Inna ; Hannou, Sarah A. ; George, Tabitha ; Arlotto, Michelle ; Olson, Lyra B. ; Lai, Michelle ; Zhang, Guo Fang ; Ilkayeva, Olga ; Herman, Mark A. ; Wynn, R. Max ; Chuang, David T. ; Newgard, Christopher B. / The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase. In: Cell Metabolism. 2018.
@article{2b2616e3b6b2479c9ab117eeb0edc287,
title = "The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase",
abstract = "Branched-chain amino acids (BCAA) are strongly associated with dysregulated glucose and lipid metabolism, but the underlying mechanisms are poorly understood. We report that inhibition of the kinase (BDK) or overexpression of the phosphatase (PPM1K) that regulates branched-chain ketoacid dehydrogenase (BCKDH), the committed step of BCAA catabolism, lowers circulating BCAA, reduces hepatic steatosis, and improves glucose tolerance in the absence of weight loss in Zucker fatty rats. Phosphoproteomics analysis identified ATP-citrate lyase (ACL) as an alternate substrate of BDK and PPM1K. Hepatic overexpression of BDK increased ACL phosphorylation and activated de novo lipogenesis. BDK and PPM1K transcript levels were increased and repressed, respectively, in response to fructose feeding or expression of the ChREBP-β transcription factor. These studies identify BDK and PPM1K as a ChREBP-regulated node that integrates BCAA and lipid metabolism. Moreover, manipulation of the BDK:PPM1K ratio relieves key metabolic disease phenotypes in a genetic model of severe obesity. Branched-chain amino acids (BCAA) are strongly associated with metabolic diseases. White et al. demonstrate that the kinase (BDK) and phosphatase (PPM1K) that regulate a rate-limiting BCAA metabolic enzyme, BCKDH, also regulate ATP-citrate lyase, a key lipogenic enzyme, thus identifying a new regulatory node that integrates BCAA and lipid metabolism.",
keywords = "ATP-citrate lyase, branched-chain amino acids, diabetes, lipid metabolism, obesity, systems physiology",
author = "White, {Phillip J.} and McGarrah, {Robert W.} and Grimsrud, {Paul A.} and Tso, {Shih Chia} and Yang, {Wen Hsuan} and Haldeman, {Jonathan M.} and Thomas Grenier-Larouche and Jie An and Lapworth, {Amanda L.} and Inna Astapova and Hannou, {Sarah A.} and Tabitha George and Michelle Arlotto and Olson, {Lyra B.} and Michelle Lai and Zhang, {Guo Fang} and Olga Ilkayeva and Herman, {Mark A.} and Wynn, {R. Max} and Chuang, {David T.} and Newgard, {Christopher B.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.cmet.2018.04.015",
language = "English (US)",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",

}

TY - JOUR

T1 - The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase

AU - White, Phillip J.

AU - McGarrah, Robert W.

AU - Grimsrud, Paul A.

AU - Tso, Shih Chia

AU - Yang, Wen Hsuan

AU - Haldeman, Jonathan M.

AU - Grenier-Larouche, Thomas

AU - An, Jie

AU - Lapworth, Amanda L.

AU - Astapova, Inna

AU - Hannou, Sarah A.

AU - George, Tabitha

AU - Arlotto, Michelle

AU - Olson, Lyra B.

AU - Lai, Michelle

AU - Zhang, Guo Fang

AU - Ilkayeva, Olga

AU - Herman, Mark A.

AU - Wynn, R. Max

AU - Chuang, David T.

AU - Newgard, Christopher B.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Branched-chain amino acids (BCAA) are strongly associated with dysregulated glucose and lipid metabolism, but the underlying mechanisms are poorly understood. We report that inhibition of the kinase (BDK) or overexpression of the phosphatase (PPM1K) that regulates branched-chain ketoacid dehydrogenase (BCKDH), the committed step of BCAA catabolism, lowers circulating BCAA, reduces hepatic steatosis, and improves glucose tolerance in the absence of weight loss in Zucker fatty rats. Phosphoproteomics analysis identified ATP-citrate lyase (ACL) as an alternate substrate of BDK and PPM1K. Hepatic overexpression of BDK increased ACL phosphorylation and activated de novo lipogenesis. BDK and PPM1K transcript levels were increased and repressed, respectively, in response to fructose feeding or expression of the ChREBP-β transcription factor. These studies identify BDK and PPM1K as a ChREBP-regulated node that integrates BCAA and lipid metabolism. Moreover, manipulation of the BDK:PPM1K ratio relieves key metabolic disease phenotypes in a genetic model of severe obesity. Branched-chain amino acids (BCAA) are strongly associated with metabolic diseases. White et al. demonstrate that the kinase (BDK) and phosphatase (PPM1K) that regulate a rate-limiting BCAA metabolic enzyme, BCKDH, also regulate ATP-citrate lyase, a key lipogenic enzyme, thus identifying a new regulatory node that integrates BCAA and lipid metabolism.

AB - Branched-chain amino acids (BCAA) are strongly associated with dysregulated glucose and lipid metabolism, but the underlying mechanisms are poorly understood. We report that inhibition of the kinase (BDK) or overexpression of the phosphatase (PPM1K) that regulates branched-chain ketoacid dehydrogenase (BCKDH), the committed step of BCAA catabolism, lowers circulating BCAA, reduces hepatic steatosis, and improves glucose tolerance in the absence of weight loss in Zucker fatty rats. Phosphoproteomics analysis identified ATP-citrate lyase (ACL) as an alternate substrate of BDK and PPM1K. Hepatic overexpression of BDK increased ACL phosphorylation and activated de novo lipogenesis. BDK and PPM1K transcript levels were increased and repressed, respectively, in response to fructose feeding or expression of the ChREBP-β transcription factor. These studies identify BDK and PPM1K as a ChREBP-regulated node that integrates BCAA and lipid metabolism. Moreover, manipulation of the BDK:PPM1K ratio relieves key metabolic disease phenotypes in a genetic model of severe obesity. Branched-chain amino acids (BCAA) are strongly associated with metabolic diseases. White et al. demonstrate that the kinase (BDK) and phosphatase (PPM1K) that regulate a rate-limiting BCAA metabolic enzyme, BCKDH, also regulate ATP-citrate lyase, a key lipogenic enzyme, thus identifying a new regulatory node that integrates BCAA and lipid metabolism.

KW - ATP-citrate lyase

KW - branched-chain amino acids

KW - diabetes

KW - lipid metabolism

KW - obesity

KW - systems physiology

UR - http://www.scopus.com/inward/record.url?scp=85047196024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047196024&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2018.04.015

DO - 10.1016/j.cmet.2018.04.015

M3 - Article

C2 - 29779826

AN - SCOPUS:85047196024

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

ER -